It was a busy week last week in TriviumVet as we were delighted to be a sponsor of the European College of Veterinary Pharmacology and Toxicology Cardiorenal Symposium. Our CRA Aisling Farrell attended ECVPT Cardiorenal Therapeutics Symposium for Practitioners in Bruges. It was reported to be a very interesting session, showcasing highlights of recent exciting research taking place in the cardiorenal space. A special thanks to the Chair of the Symposium, Professor Jonathan Elliott from RVC and all of the fantastic speakers on the day’ Jenny Wilshaw(Royal Veterinary College, London, UK)
Adrian Boswood(Royal Veterinary College, London, UK)
Pascale Smets (Faculty of Veterinary Medicine, Ghent, Belgium)
Harriet Syme (Royal Veterinary College, London, UK)
Astrid van Dongen (Faculty of Veterinary Medicine, Utrecht, the Netherlands)
Dominique Paepe (Faculty of Veterinary Medicine, Ghent, Belgium)
Sarah Spencer (Royal Veterinary College, London, UK) Details of TriviumVet's Feline HCM Research was shared with participants as well as a progress update on the development of Felycin, TriviumVet's patented companion animal mTOR inhibitor. Information on TriviumVet's Feline CKD study - REVERSE was also shared as the pilot study is OPEN and recruiting cats at The Ohio State University and University of Florida. Great to be amongst so many exciting animal health companies doing ground-breaking research.